$XMTR

Katharine Weymouth, Xometry director, sells $947,668 in stock

Xometry director Katharine Weymouth sold 10,000 shares for $947,668 in August 2026, following option exercises. Xometry's stock has risen 87% in a year, with a $5.31B market cap. The company reported Q2 2026 earnings beating estimates, with JPMorgan initiating coverage with an overweight rating and $120 target.

Original reporting
Published Sep 1, 2026, 8:29 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 1, 2026, 9:04 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$XMTR
Neutral
medium confidence
Mentioned
$XMTR
Relevance
4/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$XMTRNeutralLow
01

Why it matters

The insider sale adds a modest negative signal, but earnings beat and upgraded coverage provide a net neutral outlook.

02

Market read

While the insider transaction is new, its size and context limit trading relevance; earnings beat remains the primary driver.

03

What to watch

Recent earnings beat and JPMorgan coverage may offset any negative sentiment from the sale.

Relevance 4/10Novelty 4/10Timing: post‑market September 1

Background

XMTR reported Q2 2026 earnings beating expectations and received new JPMorgan coverage.

Company-level read

Ticker impact

$XMTRNeutralMedium confidence
Context

SEC Form 4 disclosed director Katharine Weymouth sold $947,668 of XMTR shares in late August.

Expected impact

Minimal short-term price pressure, unlikely to move beyond normal volatility.

Evidence & confidence

Sale amount <$1M and represents a small fraction of holdings; market typically discounts such modest insider sales.

Market effects

None; insider sale does not affect broader manufacturing services sector.

None; limited to U.S. investors in XMTR.

Low; no cross‑border implications.

Counterpoint

Insider may be diversifying; the sale could be unrelated to company fundamentals.

Key entities

  • Katharine Weymouth

    Sold 10,000 XMTR shares for $947,668.

  • Xometry, Inc.

    Manufacturing marketplace that posted strong Q2 results.

Related articles

$XMTRMedAI 8/10

Six Montgomery County companies attract more than $566 million in capital investment – WTOP News

Six Montgomery County companies raised over $566 million in Q3. Forbright (Nasdaq) completed an IPO, raising $142.2 million. Xometry (Nasdaq) announced a $225 million secondary offering. RegenxBio (Nasdaq) raised $90.04 million in a public offering. Georgiamune secured $92.69 million in venture funding. Arculus Solutions raised $1.95 million in Seed-1 funding. Jesse & Ben raised $15 million in Series A funding.

$XMTRHighAI 9/10

Xometry (XMTR) Q2 2026 Earnings Call Transcript

Xometry (XMTR) reported Q2 2026 revenue of $229.3 million, up 41% year over year, with marketplace revenue of $215.4 million (+45%). Adjusted EBITDA was $14.1 million, and non-GAAP net income was $9.9 million. The company raised Q3 2026 revenue guidance to $234 million to $236 million and full-year 2026 revenue growth to 33% to 34%.

$XMTRMed

Xometry, Inc. Q2 2026 Earnings Call Summary

Xometry, Inc. reported Q2 2026 results and said revenue growth accelerated for a fourth straight quarter, driven by a product-led shift toward an AI ecosystem. It cited improved CNC cost prediction accuracy (+~15%), record 175 net new enterprise accounts over $50,000, and reduced ad spend to 3.4% of revenue. Full-year 2026 revenue growth guidance raised to 33%-34% and marketplace gross margin target 35%-40%. Cash was $517M after a $248M follow-on and $50M Siemens investment.

$XMTRHighAI 9/10

Xometry, Inc.: Xometry Reports Record Second Quarter 2026 Results

Xometry (NASDAQ: XMTR) reported Q2 2026 results: revenue rose 41% to $229 million, with marketplace revenue up 45% to $215 million. Gross profit increased 34% to $87.2 million and Adjusted EBITDA rose $10.2 million to $14.1 million. Cash and equivalents were $517 million after a June equity offering. Q3 guidance calls for $234-$236 million revenue and $16-$17 million Adjusted EBITDA.